USP42 and cancer: In 2006, a case report first uncovered USP42 and RUNX1 fusion protein in acute myeloid leukemia (AML), and confirmed that this DUB was expressed in bone marrow and some cancer cells.[40] Over the next two decades, the biological functions of USP42 in several cell types have partially been elucidated.